Privia Health Group (NASDAQ:PRVA) Now Covered by Citigroup

Investment analysts at Citigroup initiated coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research note issued on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $25.00 price target on the stock. Citigroup’s price objective points to a potential upside of 32.98% from the company’s current price.

PRVA has been the subject of a number of other reports. UBS Group dropped their price objective on Privia Health Group from $31.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, March 1st. Truist Financial dropped their price objective on Privia Health Group from $32.00 to $28.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Canaccord Genuity Group dropped their price objective on Privia Health Group from $41.00 to $37.00 and set a “buy” rating for the company in a research note on Tuesday, March 19th. JPMorgan Chase & Co. dropped their price objective on Privia Health Group from $38.00 to $30.00 and set an “overweight” rating for the company in a research note on Wednesday, March 6th. Finally, Evercore ISI dropped their price objective on Privia Health Group from $26.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Privia Health Group currently has an average rating of “Moderate Buy” and an average target price of $27.92.

Privia Health Group Stock Up 4.2 %

PRVA stock opened at $18.80 on Monday. The business has a fifty day moving average of $19.99 and a two-hundred day moving average of $21.33. The stock has a market cap of $2.23 billion, a price-to-earnings ratio of 98.95, a price-to-earnings-growth ratio of 2.47 and a beta of 0.81. Privia Health Group has a 52-week low of $17.54 and a 52-week high of $30.15.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). The business had revenue of $440.80 million for the quarter, compared to analyst estimates of $425.81 million. Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. Privia Health Group’s revenue was up 21.0% compared to the same quarter last year. During the same period last year, the business earned $0.14 EPS. As a group, sell-side analysts anticipate that Privia Health Group will post 0.26 EPS for the current year.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 3,933 shares of Privia Health Group stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total transaction of $69,889.41. Following the completion of the sale, the chief financial officer now directly owns 262,279 shares of the company’s stock, valued at approximately $4,660,697.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 14.20% of the stock is currently owned by insiders.

Institutional Trading of Privia Health Group

A number of institutional investors have recently bought and sold shares of the business. Covestor Ltd lifted its holdings in Privia Health Group by 8.3% during the 3rd quarter. Covestor Ltd now owns 6,703 shares of the company’s stock worth $154,000 after buying an additional 514 shares during the last quarter. Yousif Capital Management LLC lifted its holdings in Privia Health Group by 1.1% during the 4th quarter. Yousif Capital Management LLC now owns 52,628 shares of the company’s stock worth $1,212,000 after buying an additional 563 shares during the last quarter. New York State Common Retirement Fund lifted its holdings in Privia Health Group by 2.7% during the 3rd quarter. New York State Common Retirement Fund now owns 27,966 shares of the company’s stock worth $643,000 after buying an additional 737 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Privia Health Group by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock worth $176,000 after buying an additional 756 shares during the last quarter. Finally, Glenmede Trust Co. NA lifted its holdings in Privia Health Group by 0.9% during the 3rd quarter. Glenmede Trust Co. NA now owns 107,711 shares of the company’s stock worth $2,477,000 after buying an additional 976 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.